The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Patel, Anand
One or more keywords matched the following properties of Patel, Anand
PropertyValue
keywords Leukemia, Myeloid, Acute
keywords Acute Lymphoblastic Leukemia
overview Dr. Patel is an expert in the treatment of myeloproliferative neoplasms, myelodysplastic syndromes, and leukemia. He is an active researcher whose work is focused on the development of clinical trials to investigate novel therapies that may improve the standard of care for patients with myeloid cancers and leukemia. Dr. Patel has published his research in several well-respected peer-reviewed journals including Blood, Blood Advances, the British Journal of Haematology, Cancer, JCI Insight, and Bone Marrow Transplantation.
One or more keywords matched the following items that are connected to Patel, Anand
Item TypeName
Concept Leukemia
Concept Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Concept Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Concept Leukemia, Myelomonocytic, Chronic
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Academic Article Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.
Academic Article Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement.
Academic Article Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies.
Academic Article Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
Academic Article FOXM1 contributes to treatment failure in acute myeloid leukemia.
Academic Article Impact of race on outcomes in intermediate-risk acute myeloid leukemia.
Academic Article Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
Academic Article Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab.
Academic Article Structural racism is a mediator of disparities in acute myeloid leukemia outcomes.
Academic Article Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
Academic Article Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.
Academic Article Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Academic Article The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia.
Academic Article Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.
Academic Article Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
Academic Article Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Concept Myeloid Cell Leukemia Sequence 1 Protein
Academic Article Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
Academic Article Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia.
Academic Article Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.
Academic Article Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Academic Article Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.
Academic Article Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
Academic Article Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis.
Academic Article Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Search Criteria
  • Leukemia